Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome
NCT02340819Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2014
- Primary completion
- Nov 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teduglutide in short bowel syndrome (SBS), sponsored by Takeda. Started Dec 2014; status: completed.
02
Drugs
teduglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT02340819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02340819.